Dang-Gui-Bu-Xai-Tang modulated the immunity of tumor bearing mice

Immunopharmacology and Immunotoxicology

Volumn 25, Issue 2, 2003, Pages 259-271

  Hsieh, Chang Chi ^a   Lin, Wen Chang ^b   Lee, Miau Rong ^a   Hsu, Shih Lan ^c   Liu, Hsiao Sheng ^d   Kao, Shung Te ^e   Hsieh, Ming Tsuen ^a  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

^c TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^d NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^e CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Antitumor; Dang Gui Bu Xai Tang; Immunomodulation; Tumor necrosis factor

Indexed keywords

ANGELICA SINENSIS EXTRACT; ASTRAGALUS MEMBRANACEUS EXTRACT; DANG GUI BU XAI TANG; HERBACEOUS AGENT; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER PATIENT; CELL PROLIFERATION; CHINESE MEDICINE; CYTOTOXIC T LYMPHOCYTE; DRUG EFFECT; HELPER CELL; IMMUNOMODULATION; MONONUCLEAR CELL; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; TUMOR IMMUNITY;

3T3 CELLS; ADJUVANTS, IMMUNOLOGIC; ANIMALS; CELL LINE, TRANSFORMED; CELL SURVIVAL; DRUGS, CHINESE HERBAL; IMMUNITY; LYMPH NODES; MICE; MICE, INBRED BALB C; NEOPLASM TRANSPLANTATION; NEOPLASMS, EXPERIMENTAL; SPLEEN; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, CYTOTOXIC; T-LYMPHOCYTES, HELPER-INDUCER; TUMOR NECROSIS FACTOR-ALPHA;

ANGELICA SINENSIS; ANIMALIA; ASTRAGALUS MEMBRANACEUS; MURINAE;

EID: 0037570728     PISSN: 08923973     EISSN: None     Source Type: Journal    
DOI: 10.1081/IPH-120020474     Document Type: Article

References (32)

1. Yuan, G. A review of studies on the resources of Chinese herbal drugs in recent years. Zhongguo Zhongyao Zazhi 1997, 22, 451.
2. Xin, H.; Hou, L.; Xcu, S.; Zhou, X. Progress in the immunopharmacological study of yupingfeng powder. Zhongguo Zhongyao Zazhi 1998, 23, 505.
3. Mori, K.; Kido, T.; Daikuhara, H.; Sakakibara, I.; Sakata, T.; Shimizu, K.; Amagaya, S.; Sasaki, H.; Komatsu, Y. Effect of Hochu-ekki-to (TJ-41), a Japanese herbal medicine, on the survival of mice infected with influenza virus. Antivir. Res. 1999, 44, 103.
4. Yamaoka, Y.; Kawakita, T.; Nomoto, K. Protective effect of a traditional Japanese medicine, Bu-zhong-yi-qi-tang (Japanese name: Hochu-ekki-to), on the restraint stress-induced susceptibility against Listeria monocytogenes. Immunopharmacology 2000, 48, 35.
5. Abe, S.; Tansho, S.; Ishibashi, H.; Inagaki, N.; Komatsu, Y.; Yamaguchi, H. Protective effect of oral administration of a traditional medicine, Juzen-Taiho-To, and its components on lethal Candida albicans infection in immunosuppressed mice. Immunopharmcol. Immunotoxicol. 1998, 20, 421.
6. Kaneko, M.; Kawakita, T.; Kumazawa, Y.; Takimoto, H.; Nomoto, K.; Yoshikawa, T. Accelerated recovery from cyclophosphamide-induced leukopenia in mice administered a Japanese ethical herbal drug, Hochu-ekki-to. Immunopharmacology 1999, 44, 223.
7. Zee-Cheng, R.K. Shi-quan-da-bu-tang (ten significant tonic decoction), SQT. A potent Chinese biological response modifier in cancer immunotherapy, potentiation and detoxification of anticancer drugs. Methods Find. Exp. Clin. Pharmacol. 1992, 4, 725.
8. Kido, T.; Mori, K.; Daikuhara, H.; Tsuchiya, H.; Ishige, A.; Sasaki, H. The protective effect of hochu-ekki-to (TJ-41), a Japanese herbal medicine, against HSV-1 infection in mitomycin C-treated mice. Anticancer Res. 2000, 20, 4109.
9. Suzuki, T.; Takano, I.; Nagai, F.; Fujitani, T.; Ushiyama, K.; Okubo, T.; Seto, T.; Ikeda, S.; Kano, I. Suppressive effects of Hochu-ekki-to, a traditional Chinese medicine, on IgE production and histamine release in mice immunized with ovalbumin. Biol. Pharm. Bull. 1999, 22, 1180.
10. Li, T.; Tamada, K.; Abe, K.; Tada, H.; Onoe, Y.; Tatsugami, K.; Harada, M.; Kubo, C.; Nomoto, K. The restoration of the antitumor T cell response from stress-induced suppression using a traditional Chinese herbal medicine Hochu-ekki-to (TJ-41: Bu-Zhong-Yi-Qi-Tang). Immunopharmacology 1999, 43, 11.
11. Harada, M.; Seta, K.; Ito, O.; Tamada, K.; Li, T.; Terao, H.; Takenoyama, M.; Kimura, G.; Nomoto, K. Concomitant immunity against tumor development is enhanced by the oral administration of a kampo medicine, Hochu-Ekki-To (TJ-41: Bu-Zhong-Yi-Qi-Tang). Immunophamacol. Immunotoxicol. 1995, 17, 687.
12. Cho, J.M.; Sato, N.; Kikuchi, K. Prophylactic anti-tumor effect of Hochu-ekki-to (TJ41) by enhancing natural killer cell activity. In Vivo 1991, 5, 389.
13. Kao, S.T.; Yang, S.L.; Hsieh, C.C.; Yang, M.D.; Wang, T.F.; Lin, J.G. Immunomodulation of Bu-Zhong-Yi-Qi-Tang on in vitro granulocyte colonystimulating-factor and tumor necrosis factor-alpha production by peripheral blood mononuclear cells. Immunopharmacol. Immunotoxicol. 2000, 22, 711.
14. Kao, S.T.; Yeh, C.C.; Hsieh, C.C.; Yang, M.D.; Lee, M.R.; Liu, H.S.; Lin, J.G. The Chinese medicine Bu-Zhong-Yi-Qi-Tang inhibited proliferation of hepatoma cell lines by inducing apoptosis via G0/G1 arrest. Life Sci. 2001, 69, 1485.
15. Chou, Y.P.; Huang, L.Y.; Fan, L.L.; Chang, L.Y.; Zeng, K.Y. The effect of Angelica sinensis on hemodynamics and myocardiac oxygen consumption in dogs. Yaoxue Xuebao 1979, 14, 156.
16. Pen, R.X.; Yang, D.Z.; Yi, Q.; Yu, P.; Liu, W.W.; Dang, W.J.; Xiao, D.F. Pharmacological effects of Danggui (Angelica sinensis) on cardiovascular system. Chin. Tradit. Herb Drugs 1981, 12, 321.
17. Mei, Q.B.; Tao, J.Y.; Zhang, H.D.; Duan, Z.X.; Chen, Y.Z. Effects of Angelica sinensis polysaccharides on hemopoietic stem cells in irradiated mice. Yaoxue Xuebao 1988, 9, 279.
18. Cho, C.H.; Mei, Q.B.; Shang, P.; Lee, S.S.; So, H.L.; Guo, X.; Li, Y. Study of the gastrointestinal protective effects of polysaccharides from Angelica sinensis in rats. Planta Med. 2000, 66, 348.
19. Wang, Y.; Qian, X.J.; Hadley, H.R.; Lau, B.H. Phytochemicals potentiate interleukine-2 generated lymphokine-activated killer cell cytotoxicity against murine renal cell carcinoma. Mol. Biother. 1992, 3, 143.
20. Chu, D.T.; Lin, J.R.; Wong, W. The in vitro potentiation of LAK cell cytotoxicity in cancer and AIDS patients induced by F3-a fractionated extract of Astragalus Membranaceus. Chung Hua Chung Liu Tsa Chih 1994, 16, 167.
21. Lin, W.C.; O'Connor, K.L.; Culp, L.A. Complementation of two related tumour cell classes during experimental metastasis tagged with different histochemical marker genes. Br. J. Cancer 1993, 67, 910.
22. Lin, W.C.; Pretlow, T.P.; Pretlow, T.G., 2nd. Culp, L.A. High-resolution analyses of two different classes of tumor cells in situ tagged with alternative histochemical marker genes. Am. J. Pathol. 1992, 141, 1331.
23. Lin, W.C.; Culp, L.A. Altered establishment/clearance mechanisms during experimental micrometastasis with live and/or disabled bacterial lacZ-tagged tumor cells. Invasion Metastasis 1992, 12, 197.
24. Hu, W.; Wu, W.; Yeung, S.C.; Freedman, R.S.; Kavanagh, J.J.; Verschraegen, C.F. Increased expression of heat shock protein 70 in adherent ovarian cancer and mesothelioma following treatment with manumycin, a farnesyl transferase inhibitor. Anticancer Res. 2002, 22, 665.
25. Gana-Weisz, M.; Halaschek-Wiener, J.; Jansen, B.; Elad, G.; Haklai, R.; Kloog, Y. The Ras inhibitor S-trans, trans-farnesylthiosalicylic acid chemosensitizes human tumor cells without causing resistance. Clin. Cancer Res. 2002, 8, 555.
26. Tuttle, T.M.; Inge, T.H.; McCrady, C.M.; Bethke, K.P.; Bear, H.D. Activation of CD8+ murine T cells from tumor-draining lymph nodes by phorbol dibutyrate plus calcium ionophore. J. Immunother. 1992, 12, 32.
27. Gillespie, G.Y.; Hansen, C.B.; Russell, S.W. Resurgence of killing and in vivo protection mediated by lymphocytes cultured from lymph nodes draining Moloney sarcomas. Br. J. Cancer 1978, 38, 365.
28. Shimizu, J.; Yamazaki, S.; Sakaguchi, S. Induction of tumor immunity by removing CD25+ CD4+ T cells: a common basis between tumor immunity and autoimmunity. J. Immunol. 1999, 163, 5211.
29. Shrikant, P.; Mescher, M.F. Control of syngeneic tumor growth by activation of CD8+ T cells: efficacy is limited by migration away from the site and induction of nonresponsiveness. J. Immunol. 1999, 162, 2858.
30. McKinnon, J.G.; Hoover, S.K.; Inge, T.H.; Bear, H.D. Activation and expansion of cytotoxic T lymphocytes from tumor-draining lymph nodes. Cancer Immunol. Immunother. 1990, 32, 38.
31. Holley, D.; Freeman, J.; Hamby, L.; Mattingly, C.; McGrath, P.C. In vitro cytolytic activity of lymphocytes from tumor-draining lymph nodes is associated with increased numbers of CD8+ cells and increased cytokine production. J. Surg. Res. 1995, 58, 33.
32. Wanebo, H.J. Tumor necrosis factors. Semin. Surg. Oncol. 1989, 5, 402.